BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 12563024)

  • 1. Leptin constrains phospholipase C-protein kinase C-induced insulin secretion via a phosphatidylinositol 3-kinase-dependent pathway.
    Lee JW; Swick AG; Romsos DR
    Exp Biol Med (Maywood); 2003 Feb; 228(2):175-82. PubMed ID: 12563024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin administration normalizes insulin secretion from islets of Lep(ob)/Lep(ob) mice by food intake-dependent and -independent mechanisms.
    Lee JW; Romsos DR
    Exp Biol Med (Maywood); 2003 Feb; 228(2):183-7. PubMed ID: 12563025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin constrains acetylcholine-induced insulin secretion from pancreatic islets of ob/ob mice.
    Chen NG; Swick AG; Romsos DR
    J Clin Invest; 1997 Sep; 100(5):1174-9. PubMed ID: 9276734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cyclic AMP-protein kinase A pathway restrains islet phospholipase A(2) activation.
    Simonsson E; Karlsson S; Ahrén B
    Biochem Biophys Res Commun; 2000 Mar; 269(1):242-6. PubMed ID: 10694507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wortmannin, a PI3-kinase inhibitor: promoting effect on insulin secretion from pancreatic beta cells through a cAMP-dependent pathway.
    Nunoi K; Yasuda K; Tanaka H; Kubota A; Okamoto Y; Adachi T; Shihara N; Uno M; Xu LM; Kagimoto S; Seino Y; Yamada Y; Tsuda K
    Biochem Biophys Res Commun; 2000 Apr; 270(3):798-805. PubMed ID: 10772905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leptin-deficient mice commence hypersecreting insulin in response to acetylcholine between 1 and 2 weeks of age.
    Lee JW; Romsos DR
    Exp Biol Med (Maywood); 2001 Nov; 226(10):906-11. PubMed ID: 11682696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin inhibits insulin secretion by activation of phosphodiesterase 3B.
    Zhao AZ; Bornfeldt KE; Beavo JA
    J Clin Invest; 1998 Sep; 102(5):869-73. PubMed ID: 9727054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restitution of defective glucose-stimulated insulin release of sulfonylurea type 1 receptor knockout mice by acetylcholine.
    Doliba NM; Qin W; Vatamaniuk MZ; Li C; Zelent D; Najafi H; Buettger CW; Collins HW; Carr RD; Magnuson MA; Matschinsky FM
    Am J Physiol Endocrinol Metab; 2004 May; 286(5):E834-43. PubMed ID: 14736703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired cyclic AMP response to stimuli in glucose-desensitized rat pancreatic islets.
    Laychock SG
    Mol Cell Endocrinol; 1995 Aug; 113(1):19-28. PubMed ID: 8674810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel insulin secretagogue is a phosphodiesterase inhibitor.
    Leibowitz MD; Biswas C; Brady EJ; Conti M; Cullinan CA; Hayes NS; Manganiello VC; Saperstein R; Wang LH; Zafian PT
    Diabetes; 1995 Jan; 44(1):67-74. PubMed ID: 7813816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity.
    Shafiee-Nick R; Pyne NJ; Furman BL
    Br J Pharmacol; 1995 Aug; 115(8):1486-92. PubMed ID: 8564209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin feedback actions: complex effects involving isoforms of islet nitric oxide synthase.
    Jimenez-Feltstrom J; Lundquist I; Obermuller S; Salehi A
    Regul Pept; 2004 Oct; 122(2):109-18. PubMed ID: 15380928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon plays an important role in the modification of insulin secretion by leptin.
    Shimizu H; Tsuchiya T; Ohtani K; Shimomura K; Oh-I S; Ariyama Y; Okada S; Kishi M; Mori M
    Islets; 2011; 3(4):150-4. PubMed ID: 21623172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase A-dependent stimulation of exocytosis in mouse pancreatic beta-cells by glucose-dependent insulinotropic polypeptide.
    Ding WG; Gromada J
    Diabetes; 1997 Apr; 46(4):615-21. PubMed ID: 9075801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wortmannin inhibits insulin secretion in pancreatic islets and beta-TC3 cells independent of its inhibition of phosphatidylinositol 3-kinase.
    Gao Z; Konrad RJ; Collins H; Matschinsky FM; Rothenberg PL; Wolf BA
    Diabetes; 1996 Jul; 45(7):854-62. PubMed ID: 8666133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective stimulus-secretion coupling in islets of Psammomys obesus, an animal model for type 2 diabetes.
    Nesher R; Warwar N; Khan A; Efendic S; Cerasi E; Kaiser N
    Diabetes; 2001 Feb; 50(2):308-14. PubMed ID: 11272141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.
    Scrocchi LA; Hill ME; Saleh J; Perkins B; Drucker DJ
    Diabetes; 2000 Sep; 49(9):1552-60. PubMed ID: 10969840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin inhibits insulin secretion induced by cellular cAMP in a pancreatic B cell line (INS-1 cells).
    Ahrén B; Havel PJ
    Am J Physiol; 1999 Oct; 277(4):R959-66. PubMed ID: 10516232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced sensitivity of pancreatic islets from preobese 2-week-old ob/ob mice to neurohormonal stimulation of insulin secretion.
    Chen NG; Romsos DR
    Endocrinology; 1995 Feb; 136(2):505-11. PubMed ID: 7835283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose stimulates the expression and activities of nitric oxide synthases in incubated rat islets: an effect counteracted by GLP-1 through the cyclic AMP/PKA pathway.
    Jimenez-Feltstrom J; Lundquist I; Salehi A
    Cell Tissue Res; 2005 Feb; 319(2):221-30. PubMed ID: 15558323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.